Narikazu Boku Onkologi Perubatan Gastrointestinal


Timbalan Pengarah - Hospital Pusat Kanser Nasional, Jepun, Pengalaman:

Pelantikan Buku

Mengenai Doktor

Dr. Narikazu Boku adalah antara pakar kanser GI terkemuka dan terkemuka di Tokyo, Jepun.

Dr. Narikazu Boku adalah daripada jabatan Onkologi Perubatan Gastrointestinal dan merupakan Timbalan Pengarah, Hospital Pusat Kanser Kebangsaan, Jepun.

The division of Gastrointestinal Medical Oncology focuses on the development of new drugs and establishment of standard chemotherapy regimens including multimodality treatment with surgery and/or radiotherapy for advanced esophageal/gastric/colorectal cancers, gastrointestinal stromal tumor, and other gastrointestinal (GI) malignancies. The team does not only participate in many industry-sponsored trials but also conduct investigator-initiated trials, which are associated with translational research, in collaboration with many clinicians and basic researchers in Japan, Asia, and worldwide. Recently, the team has investigated biomarkers using pretreatment tumor and blood samples, including circulating tumor cell and cell-free DNA. Because easy access to tumor samples by endoscopy is a strong point in GI malignancy, the team is now preceding to translational research using repeated biopsy samples after administering investigational drugs.

Hospital

Pusat Kanser Kebangsaan, Jepun

Pengkhususan

Onkologi Perubatan Gastrointestinal

Prosedur dilaksanakan

Penyelidikan & Penerbitan

Perlukan bantuan? Pasukan kami sedia membantu anda.

Kami menginginkan pemulihan yang cepat dari yang tersayang dan yang terdekat.

×
Mula berbual
Kami Dalam Talian! Sembang Dengan Kami!
Imbas kodnya
helo,

Selamat datang ke CancerFax !

CancerFax ialah platform perintis khusus untuk menghubungkan individu yang menghadapi kanser peringkat lanjut dengan terapi sel terobosan seperti terapi CAR T-Cell, terapi TIL dan ujian klinikal di seluruh dunia.

Beritahu kami apa yang boleh kami lakukan untuk anda.

1) Rawatan kanser di luar negara?
2) Terapi T-Cell CAR
3) Vaksin kanser
4) Perundingan video dalam talian
5) Terapi proton